Maria B. Laursen

Palle Juul Jensens Boulevard 99
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.

Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.

Journal: Molecular oncology
Published: December 15, 2023

Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfalls.

Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfalls.

Journal: Frontiers in genetics
Published: March 17, 2023

Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.

Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.

Journal: BMC cancer
Published: June 28, 2019

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients.

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients.

Journal: Oncotarget
Published: November 19, 2018

Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission.

Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission.

Journal: Experimental hematology & oncology
Published: November 03, 2016

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines.

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines.

Journal: Biomarker research
Published: May 10, 2016

Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.

Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.

Journal: PloS one
Published: November 24, 2015

High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.

High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.

Journal: Experimental hematology
Published: October 26, 2015

The application of human phase 0 microdosing trials: A systematic review and perspectives.

The application of human phase 0 microdosing trials: A systematic review and perspectives.

Journal: Leukemia & lymphoma
Published: October 03, 2015

MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.

MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.

Journal: Danish medical journal
Published: June 09, 2015

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis.

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 25, 2015

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.

Journal: BMC cancer
Published: September 25, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026